Name: UMIN ID:
Unique ID issued by UMIN | UMIN000004421 |
---|---|
Receipt number | R000005281 |
Scientific Title | Phase II study of lenalidomide consolidation/maintenance therapy after autologous stem cell transplantation in patients with symptomatic multiple myeloma. |
Date of disclosure of the study information | 2010/10/20 |
Last modified on | 2018/08/17 16:32:05 |
No. | Disposal | Last modified on | Item of update | |
---|---|---|---|---|
1 | Insert | 2010/10/20 16:47:44 | ||
2 | Update | 2011/03/01 22:24:38 | Recruitment status |
|
3 | Update | 2011/10/20 10:30:54 | Last follow-up date |
|
4 | Update | 2012/04/16 17:29:43 | Recruitment status |
|
5 | Update | 2012/04/16 17:30:55 | Post marketing survey by drug manufacture etc., specified by Japanese law. Organization1 Address1 Tel1 Email1 |
|
6 | Update | 2015/02/18 18:55:03 | Recruitment status |
|
7 | Update | 2018/06/06 13:17:02 | Last follow-up date Date of closure to data entry Date trial data considered complete Date analysis concluded Publication of results Results |
|
8 | Update | 2018/08/17 16:32:05 | Recruitment status |